Search Results - "van Vark, Laura C"

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients by VARK, Laura C. Van, BERTRAND, Michel, MARTIJN AKKERHUIS, K, BRUGTS, Jasper J, FOX, Kim, MOURAD, Jean-Jacques, BOERSMA, Eric

“…Renin-angiotensin-aldosterone system (RAAS) inhibitors are well established for the reduction in cardiovascular morbidity, but their impact on all-cause…”
Get full text

Diagnostic Value of Rigid Body Rotation in Noncompaction Cardiomyopathy by van Dalen, Bas M., MD, PhD, Caliskan, Kadir, MD, Soliman, Osama I.I., MD, PhD, Kauer, Floris, MD, van der Zwaan, Heleen B., MD, Vletter, Wim B., MSc, van Vark, Laura C., MD, ten Cate, Folkert J., MD, PhD, Geleijnse, Marcel L., MD, PhD

“…Background The diagnosis of noncompaction cardiomyopathy (NCCM) remains subject to controversy. Because NCCM is probably caused by an intrauterine arrest of…”
Get full text

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure by Vark, Laura C., Lesman‐Leegte, Ivonne, Baart, Sara J., Postmus, Douwe, Pinto, Yigal M., Boer, Rudolf A., Asselbergs, Folkert W., Wajon, Elly M. C. J., Orsel, Joke G., Boersma, Eric, Hillege, Hans L., Akkerhuis, K. Martijn, Nagelsmit, Michiel J., Brunner‐La Rocca, Hans‐Peter, Linssen, Gerard C.M., Terpstra, Willem F., Liem, Anho H., Wardeh, Alexander J., Miltenburg, Addy J.M., Bos, Ewout J., Ridder, Stijn P.J.

“…Background Several clinical studies have evaluated the association between galectin‐3 levels and outcome in patients with heart failure (HF). However, little…”
Get full text

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model by Oemrawsingh, Rohit M., Akkerhuis, K. Martijn, Van Vark, Laura C., Redekop, W. Ken, Rudez, Goran, Remme, Willem J., Bertrand, Michel E., Fox, Kim M., Ferrari, Roberto, Danser, A.H. Jan, Maat, Moniek, Simoons, Maarten L., Brugts, Jasper J., Boersma, Eric

“…Background Patients with stable coronary artery disease (CAD) constitute a heterogeneous group in which the treatment benefits by angiotensin‐converting enzyme…”
Get full text

Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure by van Vark, Laura C., Lesman-Leegte, Ivonne, Baart, Sara J., Postmus, Douwe, Pinto, Yigal M., Orsel, Joke G., Westenbrink, B. Daan, Brunner-la Rocca, Hans P., van Miltenburg, Addy J.M., Boersma, Eric, Hillege, Hans L., Akkerhuis, K. Martijn

“…Several clinical studies have evaluated the association between ST2 and outcome in patients with heart failure (HF). However, little is known about the…”
Get full text

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure by Gürgöze, Muhammed T., van Vark, Laura C., Baart, Sara J., Kardys, Isabella, Akkerhuis, K. Martijn, Manintveld, Olivier C., Postmus, Douwe, Hillege, Hans L., Lesman-Leegte, Ivonne, Asselbergs, Folkert W., Brunner-la-Rocca, Hans-Peter, van den Bos, Ewout J., Orsel, Joke G., de Ridder, Stijn P.J., Pinto, Yigal M., Boersma, Eric

“…Studies on serially measured GDF-15 (growth differentiation factor 15) in acute heart failure (HF) are limited. Moreover, several pathophysiological pathways…”
Get full text

Biomarkers of heart failure with normal ejection fraction: a systematic review by Cheng, Jin M., Akkerhuis, K. Martijn, Battes, Linda C., van Vark, Laura C., Hillege, Hans L., Paulus, Walter J., Boersma, Eric, Kardys, Isabella

“…Aims Heart failure with normal ejection fraction (HFNEF) is a major and growing public health problem, currently representing half of the heart failure burden…”
Get full text

Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure by van Boven, Nick, Kardys, Isabella, van Vark, Laura C., Akkerhuis, K. Martijn, de Ronde, Maurice W.J., Khan, Mohsin A.F., Merkus, Daphne, Liu, Zhen, Voors, Adriaan A., Asselbergs, Folkert W., van den Bos, Ewout‐Jan, Boersma, Eric, Hillege, Hans, Duncker, Dirk J., Pinto, Yigal M., Postmus, Douwe

“…Aims Previous studies have identified candidate circulating microRNAs (circmiRs) as biomarkers for heart failure (HF) using relatively insensitive arrays,…”
Get full text

Reply: Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors by van Vark, Laura C., Kardys, Isabella, Boersma, Eric, Hillege, Hans L., Akkerhuis, K. Martijn

“…In our Bio-SHiFT (The Role of Biomarkers and Echocardiography in Prediction of Prognosis of Chronic Heart Failure Patients) study of 263 patients with chronic…”
Get full text

Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study by van den Berge, Jan C, van Vark, Laura C, Postmus, Douwe, Utens, Elisabeth M W J, Hillege, Hans L, Boersma, Eric, Lesman-Leegte, Ivonne, Akkerhuis, K Martijn

“…The relation between non-cardiac comorbidities and health-related quality of life (HRQoL) in patients with heart failure (HF) has been studied to a limited…”
Get full text

CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study by Altara, Raffaele, Manca, Marco, Hessel, Marleen H., Gu, Yumei, van Vark, Laura C., Akkerhuis, K. Martijn, Staessen, Jan A., Struijker-Boudier, Harry A. J., Booz, George W., Blankesteijn, W. Matthijs

“…Chemokines are involved in the remodeling of the heart; however, their significance as biomarkers in heart failure is unknown. We observed that circulating…”
Get full text

A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction by Cheng, Jin M, Helming, Anne Mijn, van Vark, Laura C, Kardys, Isabella, Den Uil, Corstiaan A, Jewbali, Lucia SD, van Geuns, Robert-Jan, Zijlstra, Felix, van Domburg, Ron T, Boersma, Eric, Akkerhuis, K Martijn

“…Aims: Early risk stratification is important in patients with cardiogenic shock from ST-elevation myocardial infarction (STEMI). We aimed to develop a simple…”
Get full text

Lipoprotein-associated phospholipase A2 activity and risk of heart failure : the Rotterdam Study by VAN VARK, Laura C, KARDYS, Isabella, BLEUMINK, Gysèle S, KNETSCH, Anneke M, DECKERS, Jaap W, HOFMAN, Albert, STRICKER, Bruno H. Ch, WITTEMAN, Jacqueline C. M

“…Evidence is accumulating that inflammation plays a role in the pathophysiology of heart failure. Lipoprotein-associated phospholipase A2 (Lp-PLA2) has…”
Get full text

Reply by van Vark, Laura C., Kardys, Isabella, Boersma, Eric, Hillege, Hans L., Akkerhuis, K. Martijn

Get full text

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure by Gürgöze, Muhammed T., van Vark, Laura C., Baart, Sara J., Kardys, Isabella, Akkerhuis, K. Martijn, Manintveld, Olivier C., Postmus, Douwe, Hillege, Hans L., Lesman-Leegte, Ivonne, Asselbergs, Folkert W., Brunner-la-Rocca, Hans-Peter, van den Bos, Ewout J., Orsel, Joke G., de Ridder, Stijn P.J., Pinto, Yigal M., Boersma, Eric

Get full text